Sign In
Buy NDAQ
$82.49
-0.120 (-0.145%)
At Close: Jun 23, 2026
Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
04:20pm, Thursday, 01'st May 2025
CARLSBAD, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today that it received an expected deficiency notification letter from the L
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Thursday, 01'st May 2025
CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease,
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Thursday, 01'st May 2025
FLORHAM PARK, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointe
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:09pm, Thursday, 01'st May 2025
NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatme
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Thursday, 01'st May 2025
NEWTON, Mass. , May 1, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company g
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:00pm, Thursday, 01'st May 2025
CHARLESTOWN, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and ca
Nasdaq 100: Bullish Rebound in Tech Stocks Today on Strong Microsoft, Meta Earnings
09:20am, Thursday, 01'st May 2025
Tech stocks rally as Microsoft and Meta post strong earnings, lifting the Nasdaq 100 and boosting confidence in AI despite weak U.S. economic data.
Beat the Nasdaq With This Cash-Gushing Dividend Stock
08:30am, Thursday, 01'st May 2025
Reliable dividend income from high-quality companies is a great option for investors seeking to ride out stock market turbulence. Biotech giant Amgen (AMGN 0.82%) exemplifies this strategy with its 3.
Nasdaq to head Wall Street rally after Microsoft and Meta earnings beats
08:02am, Thursday, 01'st May 2025
Technology stocks are anticipated to lead a Wall Street rally to start the month of May on Thursday, following earnings from Microsoft and Meta Platforms overnight and ahead of more from Apple and Ama
Top KingWin Ltd Announces 1-For-25 Reverse Share Split
08:00am, Thursday, 01'st May 2025
Guangzhou, China, May 01, 2025 (GLOBE NEWSWIRE) -- Top KingWin Ltd (“Top KingWin” or the “Company”) (Nasdaq: WAI) today announced that it will effect a reverse share split of its outstanding c
3 Best Nasdaq Stocks to Buy in May
07:45am, Thursday, 01'st May 2025
Despite Wall Street's optimistic outlook for big tech in 2025, most technology stocks have struggled significantly during the first four months of the year. The Nasdaq-100, which consists of the 100 l
Aimfinity Investment Corp. I Announces Transition from Nasdaq to OTC Markets and New Monthly Extension for Business Combination
08:23pm, Wednesday, 30'th Apr 2025
Wilmington, DE, April 30, 2025 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the “AIMA”) (Nasdaq: AIMAU), a special purpose acquisition company, today announced that, as anticipated, AIMA rece
Oak Woods Acquisition Corporation Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
05:00pm, Wednesday, 30'th Apr 2025
New York, April 30, 2025 (GLOBE NEWSWIRE) -- Oak Woods Acquisition Corporation. (Nasdaq: OAKU) (the “Company”) today announced it received a delinquency notification letter from Nasdaq on April 2
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04:47pm, Wednesday, 30'th Apr 2025
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
Wellchange Holdings Company Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
04:30pm, Wednesday, 30'th Apr 2025
New York, April 30, 2025 (GLOBE NEWSWIRE) -- Wellchange Holdings Company Limited (NASDAQ: WCT) ("Wellchange Holdings Company" or the "Company") is an enterprise software solution services provider hea
